A detailed history of Mendota Financial Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Mendota Financial Group, LLC holds 65 shares of NVS stock, worth $7,186. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65
Previous 26 150.0%
Holding current value
$7,186
Previous $2.77 Million 169.54%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$106.13 - $120.89 $4,139 - $4,714
39 Added 150.0%
65 $7.46 Million
Q2 2024

Jul 11, 2024

BUY
$92.57 - $107.37 $2,406 - $2,791
26 New
26 $2.77 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Mendota Financial Group, LLC Portfolio

Follow Mendota Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendota Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mendota Financial Group, LLC with notifications on news.